Sectoral Funds – Weekly roundup - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Sectoral Funds – Weekly roundup

Aug 12, 2000

The BSE Sensex slid 0.2% this week to close at 4,192.0 points. The S&P CNX 50, on the other hand, climbed marginally by 0.9% to 2,092 points. In a sharp reversal of trend over the past few weeks, IT funds crawled back into the limelight.

Open-ended, IT Funds NAV
(Rs)
Last
week
Last
month
Last
year
Since
inception
IL&FS eCOM Fund (Gr) 5.7 3.7% -21.6% 0.0% -58.4%
K P Infotech (Gr) 26.8 3.0% -14.0% 102.5% 141.3%
Magnum Sector Funds-IT 14.3 2.7% -15.3% 82.7% 96.4%
Birla IT Fund (Gr) 16.9 2.2% -20.5% 30.3% 11.5%
Chola Freedom Tech (Cum) 14.6 2.2% -15.1% 0.0% 15.2%
K P Internet Opport.(Gr) 7.5 2.0% -13.6% 0.0% -21.7%
UTI Sector- Software 19.7 1.3% -17.9% 0.0% 51.0%
K Tech 6.9 0.7% -16.2% 0.0% -11.9%
Alliance New Millenn (Gr) 7.4 0.1% -19.0% 0.0% -51.5%
Tata IT Sector Fund 10.6 0.0% -18.3% 42.7% 20.7%
DSP ML Tech.com (Gr) 7.5 -0.5% -20.4% 0.0% -12.6%
Pru ICICI Tech. (Gr) 5.3 -0.6% -16.9% 0.0% -46.3%

IT is back…for a change. That is not to say that all those concerns about IT valuations are a thing of the past. On the contrary, even at this stage with IT stocks having climbed during the week, it would take a brave analyst to comment on the prospects of IT stocks in the coming months. Fund managers in any case won’t be complaining too much, as IT funds witnessed some upward movement, at long last. The rise in NAVs of most IT funds can be attributed to the surge in prices of Infosys, Visualsoft and Satyam. However, the character (or lack of it) of this rally (?) can be gauged by the slump in these stocks on Friday.

Open-ended, Pharma Funds NAV
(Rs)
Last
week
Last
month
Last
year
Since
inception
K P Pharma (Gr) 9.6 -1.0% -5.4% -11.0% 2.4%
Magnum Sector Funds-Pharma 9.6 -1.2% -6.1% -10.0% -4.9%
UTI Sector-Pharma 9.8 -1.4% -8.9% 0.0% -17.8%

If IT stocks got the fund managers in the right mood, pharma stocks most certainly didn’t. Pharma stocks saw a downslide and this was reflected in the NAVs of pharma funds. The scenario in the coming weeks for pharma stocks (both MNC and Indian) is unlikely to be very different.

Open-ended, FMCG Funds NAV
(Rs)
Last
week
Last
month
Last
year
Since
inception
Pru ICICI FMCG (Gr) 9.7 -0.9% -2.8% -12.9% -4.5%
K P FMCG (Gr) 11.8 -1.2% -3.0% 2.7% 15.2%
Magnum Sector Funds-FMCG 8.2 -3.9% -8.6% -22.5% -20.0%

If pharma stocks spoilt the mood, FMCG stocks really rubbed it in. This is because FMCG stocks are witnessing a sustained decline despite companies posting some reasonable (and even impressive) earnings growth. What is even more strange is that fund managers we have spoken to, keep telling us about the potential in FMCG, but evidently there seems to be little more than plain talk.


Equitymaster requests your view! Post a comment on "Sectoral Funds – Weekly roundup ". Click here!

  

More Views on News

Sorry! There are no related views on news for this company/sector.

Most Popular

Why We Picked This Small-cap Stock for Our Hidden Treasure Subscribers (Profit Hunter)

Sep 17, 2020

This leading household brand will profit big time in a post covid world.

My Top Stock to Buy in this Market Selloff (Profit Hunter)

Sep 22, 2020

The recent correction offers a great opportunity to buy this high conviction smallcap stock.

Can the Nifty Fall to 10,200? (Fast Profits Daily)

Sep 24, 2020

The Nifty has reached an important support level today. If it breaks then we could see further downside.

What Do the Charts Say About Buying Smallcaps Now? (Fast Profits Daily)

Sep 18, 2020

Everyone seems to be excited about buying smallcaps now...but is it the right thing to do? What do the charts tell us? Find out in this video...

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

MARKET STATS